Treating Influenza and SARS-CoV-2 via mRNA-encoded Cas13a
Emmeline L. Blanchard(Georgia Institute of Technology), Philip J. Santangelo(Georgia Institute of Technology), Laura Rotolo(Georgia Institute of Technology), Swapnil Bawage(Georgia Institute of Technology), M. G. Finn(Georgia Institute of Technology), Daryll Vanover(Georgia Institute of Technology), Jared Beyersdorf(Georgia Institute of Technology), Eric R. Lafontaine(University of Georgia), Chiara Zurla(Georgia Institute of Technology), Robert Hincapie(Georgia Institute of Technology), Robert J. Hogan(United States Army Medical Research Institute of Infectious Diseases), Hannah E. Peck(Georgia Institute of Technology), Pooja Tiwari(Georgia Institute of Technology), Frank Michel(University of Georgia), Nicholas C. Bruno(University of Central Florida)
Cited by 5
Related Papers
Functionalized Gold Nanoparticles and Their Biomedical Applications
|Nanomaterials|2011|831
Bioorthogonal chemistry
|Nature Reviews Methods Primers|2021|554
Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation
|The Journal of Infectious Diseases|2003|293
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents
|Nature Biotechnology|2021|237
<i>N</i>-Substituted 2-Aminobiphenylpalladium Methanesulfonate Precatalysts and Their Use in C–C and C–N Cross-Couplings
|The Journal of Organic Chemistry|2014|226